In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate

Jacques P Brown; Michael A Bolognese; Pei-Ran Ho; Christian Roux; Henry G Bone; Sydney L Bonnick; den Bergh Joop van; Irene Ferreira; Prayashi Ghelani; Paula Dakin; Rachel B Wagman; Christopher Recknor

doi:10.1530/boneabs.3.PP357

OP7

Prev Next

Section Contents Cite

Bone Abstracts (2014) 3 OP7 | DOI: 10.1530/boneabs.3.PP357

ECTS2014 Oral Posters Clinical (20 abstracts)

In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate

Jacques P Brown , Michael A Bolognese , Pei-Ran Ho , Christian Roux , Henry G Bone , Sydney L Bonnick , Joop van den Bergh , Irene Ferreira , Prayashi Ghelani , Paula Dakin , Rachel B Wagman & Christopher Recknor

see PP357.

Volume 3

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

European Calcified Tissue Society

Browse other volumes

Summary Abstract Book Programme Volume Editors eposters Abstracts

Article tools

| Disclaimer

My recent searches

No recent searches

My recently viewed abstracts

MIV-711, a highly selective cathepsin K inhibitor: safety, pharmacokinetics and pharmacodynamics of multiple oral doses in healthy postmenopausal women (<1 min ago)

Zoledronate prevents lactation induced loss of bone strength and micro-architecture (<1 min ago)

Do osteophytes protect femoral neck against fracture in osteoarthritis? (<1 min ago)

Regional differences in microstructural and mechanical properties of the distal femur in health and osteoarthritis (<1 min ago)

In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate (<1 min ago)

Authors

Bone Abstracts Google Scholar Pub Med

Bone Abstracts

OP7

In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate

Jacques P Brown , Michael A Bolognese , Pei-Ran Ho , Christian Roux , Henry G Bone , Sydney L Bonnick , Joop van den Bergh , Irene Ferreira , Prayashi Ghelani , Paula Dakin , Rachel B Wagman & Christopher Recknor

Volume 3

European Calcified Tissue Society Congress 2014

Article tools

My recent searches

My recently viewed abstracts

Authors

Brown Jacques P

Bolognese Michael A

Ho Pei-Ran

Roux Christian

Bone Henry G

Bonnick Sydney L

van den Bergh Joop

Ferreira Irene

Ghelani Prayashi

Dakin Paula

Wagman Rachel B

Recknor Christopher

BiosciAbstracts